Cochlear ( ) - 株価, ニュースと分析ASX:COH

COH 株式概要

コクレア社は、世界中の小児および成人の聴覚障害者にインプラント聴覚ソリューションを提供している。

COH ファンダメンタル分析
スノーフレーク・スコア
評価	0/6
将来の成長	3/6
過去の実績	3/6
財務の健全性	6/6
配当金	0/6

報酬

収益は年間11.39%増加すると予測されています

過去5年間の収益は年間22.8%増加しました。

リスク分析

COH リスクチェックを通過した。

Cochlear Limited 競合他社

Sonic Healthcare

ASX:SHL

AU$12.8b

Ramsay Health Care

ASX:RHC

AU$9.0b

Austco Healthcare

ASX:AHC

AU$94.7m

Ansell

ASX:ANN

AU$4.5b

価格と性能

の歴代最高値、変動、値下がりまとめCochlear
過去の株価
現在の株価	AU$285.05
52週高値	AU$350.31
52週安値	AU$245.68
ベータ	0.47
11ヶ月の変化	-2.37%
3ヶ月変化	-15.93%
1年変化	15.13%
33年間の変化	21.27%
5年間の変化	33.31%
IPOからの変化	9,562.71%

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Oct 18

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Sep 19

Recent updates

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Oct 18

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Sep 19

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Aug 16

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Oct 04

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Sep 12

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Jun 05

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Apr 05

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Mar 04

Is Cochlear (ASX:COH) A Risky Investment?

Dec 19

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

Nov 16

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Oct 25

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Oct 11

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Aug 23

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Jul 16

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

May 19

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Apr 09

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

Feb 04

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Dec 24

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Oct 30

This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

Oct 12

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Oct 06

Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)

Aug 16

Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet

Jun 24

A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)

May 17

There Are Reasons To Feel Uneasy About Cochlear's (ASX:COH) Returns On Capital

Apr 29

These 4 Measures Indicate That Cochlear (ASX:COH) Is Using Debt Reasonably Well

Mar 20

株主還元

	COH	AU Medical Equipment	AU 市場
7D	0.4%	-0.6%	-1.1%
1Y	15.1%	15.2%	16.1%

業界別リターン: COH過去 1 年間で15.2 % のリターンをもたらしたAustralian Medical Equipment業界と一致しました。

リターン対市場: COHは、過去 1 年間で16.1 % のリターンをもたらしたAustralianマーケットと一致しました。

価格変動

Is COH's price volatile compared to industry and market?
COH volatility
COH Average Weekly Movement	3.4%
Medical Equipment Industry Average Movement	10.1%
Market Average Movement	8.7%
10% most volatile stocks in AU Market	17.7%
10% least volatile stocks in AU Market	3.6%

安定した株価: COH過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: COHの週次ボラティリティ ( 3% ) は過去 1 年間安定しています。

会社概要

設立	従業員	CEO（最高経営責任者	ウェブサイト
1981	5,047	Dig Howitt	www.cochlear.com

コクレア社は、小児から成人までの人工内耳を世界中に提供している。人工内耳システム、サウンドプロセッサーのアップグレード、骨伝導システム、アクセサリーなどを提供している。同社は1981年に設立され、オーストラリアのシドニーに本社を置いている。

Cochlear Limited 基礎のまとめ

Cochlear の収益と売上を時価総額と比較するとどうか。
COH 基礎統計学
時価総額	AU$18.66b
収益（TTM）	AU$356.80m
売上高(TTM)	AU$2.24b

52.3x

PER（株価収益率

8.3x

P/Sレシオ

COH は割高か？

公正価値と評価分析を参照

収益と収入

最新の決算報告書（TTM）に基づく主な収益性統計
COH 損益計算書（TTM）
収益	AU$2.24b
売上原価	AU$562.10m
売上総利益	AU$1.67b
その他の費用	AU$1.32b
収益	AU$356.80m

直近の収益報告

Jun 30, 2024

次回決算日

Feb 13, 2025

一株当たり利益（EPS）	5.45
グロス・マージン	74.86%
純利益率	15.96%
有利子負債／自己資本比率	0%

COH の長期的なパフォーマンスは？

過去の実績と比較を見る

配当金

1.5%

現在の配当利回り

75%

配当性向

COH 株式概要

報酬

リスク分析

Cochlear Limited 競合他社

ASX:SHL

AU$12.8b

ASX:RHC

AU$9.0b

ASX:AHC

AU$94.7m

ASX:ANN

AU$4.5b

価格と性能

最新ニュース

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Now 20% overvalued

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

CEO, MD exercised options and sold AU$613k worth of stock

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Upcoming dividend of AU$2.10 per share

Recent updates

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Now 20% overvalued

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

CEO, MD exercised options and sold AU$613k worth of stock

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Upcoming dividend of AU$2.10 per share

Final dividend of AU$2.10 announced

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS misses analyst expectations

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Upcoming dividend of AU$2.00 per share

First half dividend increased to AU$2.00

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

First half 2024 earnings: EPS in line with expectations, revenues disappoint

Price target increased by 7.0% to AU$272

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Upcoming dividend of AU$1.75 per share at 1.2% yield

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$1.55 per share at 1.3% yield

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Is Cochlear (ASX:COH) A Risky Investment?

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Key Executive recently bought AU$97k worth of stock

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Upcoming dividend of AU$1.45 per share

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Full year 2022 earnings: EPS misses analyst expectations

Cochlear Announces Final Dividend Payable on 17 October 2022

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Upcoming dividend of AU$1.55 per share

Investor sentiment improved over the past week

First half 2022 earnings: EPS and revenues exceed analyst expectations